Unilever’s £50 Billion Bid for GSK Unit Marks Health Pivot
- CEO Jope says company may divest lower-growth food brands
- Unilever is considering raising offer for GSK Consumer
This article is for subscribers only.
Unilever Plc plans to sharpen its focus on health and hygiene and sell off slow-growth brands as it weighs making a higher offer for GlaxoSmithKline Plc’s consumer unit.
The Dove soap owner said Monday it will announce a revamp of its structure later this month. The company will refocus around its health, beauty and hygiene operations, suggesting divestitures may involve its food operations, which include the Ben & Jerry’s and Magnum ice cream brands.